Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Beraprost sodium

EU orphan designation number: EU/3/01/053
Active ingredient: Beraprost sodium
Indication: Treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Sponsor: Aventis Pharma S.A.
20 avenue Raymond Aron, 92165 Antony CEDEX, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/09/2001 Orphan designation EMEA/OD/015/01 (2001)2713 of 18/09/2001
19/02/2004 Removal of orphan designation from Community Register